@castltrastondrs.medsky.network#Medsky🧪 #immunosky #oncosky #Lymphocyteactivationgene3 (LAG3) protein is a key immune inhibitory checkpoint receptor that suppresses #Tcell activation, proliferation and effector functions to maintain immune homeostasis and tolerance. In persistent pathological settings,
@jlbjournal.bsky.socialXi Wang, Sven Brandau and colleagues show that #Neutrophils and #Macrophages differentially shape CD8+ #Tcell activity in the head and neck squamous cell carcinoma (#HNSCC) tumor microenvironment
@senolonay.bsky.social@castltrastondrs.medsky.network#Medsky🧪 #Microsky #immunosky #publichealth The autoimmune regulator (Aire) promotes #Tcell tolerance through promiscuous #geneexpression in medullary thymic epithelial cells, but growing evidence points to additional roles beyond thymic tolerance
@cellpress.bsky.social
www.cell.com/immunity/ful...
@labsoap.bsky.social
@science.orgNew results in #ScienceSignaling reveal that the T cell adaptor protein PAG supports the function of #TCell immune synapses by connecting with actin, suggesting that it could offer a target to improve #immunotherapy in patients that show poor responses. https://scim.ag/3V1ilCa
@borsacoo.bsky.socialTurkcell Finansman, Türkiye’de 6 Milyar TL’ye kadar, 12 aya kadar vadeli kira sertifikası ihraç edecek. SPK onayı bekleniyor.
@borsacoo.bsky.socialTurkcell’in bağlı ortaklığı BEST’in sermayesi toplam 7 Milyon dolar artırılacak; 5 Milyon dolar Ekim 2026, 2 Milyon dolar Aralık 2026’da ödenecek.
@immunologypodcast.com🔔 The wait is over!
Tune into our discussion with Dr. Roger Geiger at @irbbellinzona.bsky.social on the metabolic regulation of #TCell function and engineering bacteria to deliver therapeutic payloads directly to tumors. 🦠
Listen now! https://bit.ly/3VE92Ik
@borsacoo.bsky.socialTurkcell’in yüzde 100 bağlı ortaklığı Turktell’in sermayesi 8 Milyar TL artırılarak 45,22 Milyar TL’ye çıktı; paylar nakden ödendi.
@borsacoo.bsky.socialTurkcell, SEC düzenlemesi kapsamında yöneticilerinin pay ve türev araç bakiyelerine ilişkin zorunlu bildirimleri kamuya açıkladı.
@immunologypodcast.com📢 Stay tuned for Dr. Roger Geiger from @irbbellinzona.bsky.social!
His lab studies molecular regulations underlying #TCell activation and anti-tumor activity, aiming to provide detailed insights into T cell functionality that can be translated into the clinic.
🧫 Latest work: https://bit.ly/3SCeRoT
@scienceinseattle.comDr. Martin Prlic from @fredhutch.org is the latest guest on the @immunologypodcast.com!
🎙️ Check out the episode now to hear how his lab uses advanced single-cell technologies to understand #TCell responses across healthy, inflamed, and tumor tissues: https://bit.ly/46jY7G8
@en.nagoya-u.ac.jp[Research] 🏥 💊 Hard-to-treat #NephroticSyndrome can go into remission with the drug RTX, but doctors can't anticipate who it will help. Nagoya University researchers found #TCell changes in patients who improved that could help predict response to treatment. bit.ly/4cCsjQl 🧪 doi.org/rnqq
@borsacoo.bsky.socialTurkcell’de satıştan sorumlu GMY Kadri Özdal 8 Eylül 2026’da ayrılıyor, yerine 9 Eylül’de Metin Tuğtaş atanıyor.